These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 3251235)

  • 21. Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats.
    Fessler RG; Sturgeon RD; Meltzer HY
    Pharmacol Biochem Behav; 1980 Dec; 13(6):835-42. PubMed ID: 7193876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1639-43. PubMed ID: 2874567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of hormonal condition on dose-dependent amphetamine-stimulated behaviors in the male rat.
    Dluzen DE; Green MA; Ramirez VD
    Horm Behav; 1986 Mar; 20(1):1-6. PubMed ID: 3957255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opposite effects of sulpiride and metoclopramide on amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Eur J Pharmacol; 1985 Feb; 109(1):81-9. PubMed ID: 4039669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm.
    Carvey PM; Nath ST; Kao LC; Zhang TJ; Lin DH; Singh R; Amdur RL; Klawans HL
    Eur J Pharmacol; 1990 Aug; 184(1):43-53. PubMed ID: 2209714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic control of pemoline induced self-injurious behavior in rats.
    Mueller K; Nyhan WL
    Pharmacol Biochem Behav; 1982 Jun; 16(6):957-63. PubMed ID: 6213967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats.
    Gattaz WF; Schummer B; Behrens S
    J Neural Transm Gen Sect; 1994; 96(3):227-32. PubMed ID: 7826573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A lever-release version of the conditioned avoidance response paradigm: effects of haloperidol, clozapine, sulpiride, and BMY-14802.
    White IM; Ciancone MT; Haracz JL; Rebec GV
    Pharmacol Biochem Behav; 1992 Jan; 41(1):29-35. PubMed ID: 1347175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of thioridazine on haloperidol induced behavioral hypersensitivity.
    Klawans HL; Carvey PM; Nelson D; Tanner CM; Goetz CG
    Life Sci; 1986 May; 38(19):1707-14. PubMed ID: 3702600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine.
    Nguyen TV; Kosofsky BE; Birnbaum R; Cohen BM; Hyman SE
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4270-4. PubMed ID: 1374894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of the behavioral effects of d-amphetamine and apomorphine in the rat.
    Antoniou K; Kafetzopoulos E
    Pharmacol Biochem Behav; 1991 May; 39(1):61-70. PubMed ID: 1924514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ascorbic acid and the behavioral response to haloperidol: implications for the action of antipsychotic drugs.
    Rebec GV; Centore JM; White LK; Alloway KD
    Science; 1985 Jan; 227(4685):438-40. PubMed ID: 4038426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats.
    Hoffman DC
    J Neural Transm Gen Sect; 1992; 89(1-2):1-10. PubMed ID: 1358122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha 2-adrenergic antagonists effect on amphetamine-induced behaviors.
    Luttinger D; Durivage ME
    Pharmacol Biochem Behav; 1986 Jul; 25(1):155-60. PubMed ID: 2875469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat.
    Bloss JL; Singer GH
    Psychopharmacology (Berl); 1978 May; 57(3):295-302. PubMed ID: 97712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel procedure for dissociating the anatomical bases of the behavioral effects of amphetamine.
    Towell A; Willner P; Muscat R
    Pharmacol Biochem Behav; 1987 Nov; 28(3):423-6. PubMed ID: 3685080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic administration of three neuroleptics: effects of behavioral supersensitivity mediated by two different brain regions in the rat.
    Halperin R; Guerin JJ; Davis KL
    Life Sci; 1983 Aug; 33(6):585-92. PubMed ID: 6684202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.
    Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
    Brain Res; 1987 Jan; 401(2):322-30. PubMed ID: 3815099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats.
    Abekawa T; Honda M; Ito K; Koyama T
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):247-56. PubMed ID: 12898123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.